Tobacco smoking and nicotine vaping in persons with first episode psychosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bennett Melanie E, Medoff Deborah, Cowan Tovah, Fang Lijuan, Kacmarek Corinne, Oikonomou Maria Theodora, Calkins Monica E, Baker Krista K, Bencivengo Donna, Boumaiz Yasmine, Buchanan Robert W, Campbell Phillip, Chengappa K N Roy, Conroy Catherine G, Cooke Akinyi, Dong Fanghong, Fauble Mandy, Goldberg Richard W, Harvin Alexander, Jumper Megan B E, Kauffman Belinda, Kelly Christian, Kohler Christian G, Kreyenbuhl Julie, Li Lan, Lucksted Alicia, Margolis Russell L, Marsteller Jill A, Moxam Alex, Namowicz Denise, Oko Jamie, Riggs Jessie, Saravana Arunadevi, Sarpal Deepak K, Scheinberg Rachel, Smith William R, States Richard, Taylor Jerome, Vatza Crystal, Wolcott Max, Dickerson Faith
Аннотация
Tobacco smoking is highly prevalent in persons with psychosis and is the leading cause of preventable mortality in this population. Less is known about tobacco smoking in persons with first episode psychosis (FEP) and there have been no estimates about the prevalence of nicotine vaping in FEP. This study reports rates of tobacco smoking and nicotine vaping in young people with FEP enrolled in Coordinated Specialty Care programs in Pennsylvania and Maryland. Using data collected from 2021 to 2023, we examined lifetime and recent smoking and vaping and compared smokers and vapers to nonusers on symptoms, functioning, and substance use. The sample included 445 participants aged 13-35 with recent psychosis onset. Assessments were collected by program staff. Overall, 28 % of participants engaged in either smoking or vaping within 30 days of the admission assessment. Smokers and vapers were disproportionately male, cannabis users, and had lower negative symptom severity than non-smokers. Vapers had higher role and social functioning. Both smoking and vaping were related to a longer time from psychosis onset to program enrollment. We compare these findings to previous studies and suggest steps for addressing smoking and vaping in this vulnerable population.